Aileen I. Fernandez

Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue

Aileen I. Fernandez, Matthew Liu, Andrew M. Bellizzi et al. · JAMA Oncology · 2022 · 332 citations · Full text

Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

Saman Farahmand, Aileen I. Fernandez, Fahad Ahmed et al. · Modern Pathology · 2021 · 152 citations · Full text

Her2+ Breast Cancer, Her2 Status, Breast Oncology +8

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Myrto Moutafi, Charles T. Robbins, Vesal Yaghoobi et al. · Laboratory Investigation · 2022 · 133 citations

Breast Oncology, Her2 Expression, Endocrine-related Cancer +9

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Charles T. Robbins, Aileen I. Fernandez, Gang Han et al. · Modern Pathology · 2023 · 85 citations · Full text

Diagnostic Test, Histopathology, Pathology +5

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Myrto Moutafi, Sandra Martínez-Morilla, Prajan Divakar et al. · Journal of Thoracic Oncology · 2022 · 37 citations · Full text

Cancer Immunosurveillance, Medicine, Biomarker Target +9